Cite
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial.
MLA
Kristensen, Søren L., et al. “Microvascular Complications in Diabetes Patients with Heart Failure and Reduced Ejection Fraction-Insights from the Beta-Blocker Evaluation of Survival Trial.” European Journal of Heart Failure, vol. 20, no. 11, Nov. 2018, pp. 1549–56. EBSCOhost, https://doi.org/10.1002/ejhf.1201.
APA
Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M. Y., Petrie, M. C., Køber, L., McMurray, J. J. V., & BEST Investigators. (2018). Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial. European Journal of Heart Failure, 20(11), 1549–1556. https://doi.org/10.1002/ejhf.1201
Chicago
Kristensen, Søren L., Rasmus Rørth, Pardeep S. Jhund, Li Shen, Matthew M. Y. Lee, Mark C. Petrie, Lars Køber, John J.V. McMurray, and BEST Investigators. 2018. “Microvascular Complications in Diabetes Patients with Heart Failure and Reduced Ejection Fraction-Insights from the Beta-Blocker Evaluation of Survival Trial.” European Journal of Heart Failure 20 (11): 1549–56. doi:10.1002/ejhf.1201.